Bicycle Therapeutics plcBCYCNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank75
3Y CAGR-2.3%
5Y CAGR+37.7%
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-2.3%/yr
vs +43.4%/yr prior
5Y CAGR
+37.7%/yr
Recent deceleration
Acceleration
-45.7pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$72.18M+19.5%
2023$60.43M-53.9%
2022$131.12M+69.6%
2021$77.31M+164.8%
2020$29.20M+100.6%
2019$14.56M-49.6%
2018$28.88M+58.1%
2017$18.27M+38.2%
2016$13.22M-